Arkema has announced the proposed acquisition by the Bostik-Nitta joint-venture of the industrial adhesives of Nitta-Gelatin Inc., as well as the construction of a new world-scale adhesives plant in Japan. These operations will enable Bostik to supply its Japanese customers in the buoyant nonwoven markets for hygiene applications and in the packaging, labelling, transportation and electronics industrial markets.
Effective 1st June 2018, Marie-José Donsion is joining Arkema as Group Chief Financial Officer, replacing Thierry Lemonnier who is taking retirement. Marie-José Donsion will also sit on the Executive Committee.
Over 8,000 Arkema employees have subscribed for 610,405 shares totaling €50 million as part of the sixth capital increase reserved for them. The amounts invested and the high participation rate highlight the employees’ confidence in the Group’s long-term strategy.
Arkema has just successfully brought on stream new Kynar® PVDF capacities in its Calvert-City plant in the United States. With this 20% increase in its US production capacities, Arkema will further support its customers’ strong demand in the region.
To complement its major project in the bio-based polyamide 11, Arkema announces a 25% expansion in its global polyamide 12 polymers production capacities to support its customers’ strong demand in Asia.
Bostik, the Specialty Adhesives business line of Arkema, continues to expand its manufacturing capacities with the opening of a new facility in Gujarat. Together with its existing plant in Bangalore, the new plant will serve the fast growing demand in India for adhesives in industrial markets.
Arkema will increase fluoropolymer (Kynar® PVDF) capacity at its Calvert City plant in the United States by some 20%. The expansion is fueled by strong demand in the new energies and water management markets as well as in more traditional applications (chemical process industry and high performance cables). In line with the strategy presented at its recent Capital Markets Day, this investment, scheduled to start mid-2018, further supports Arkema’s ambition to accelerate the development of its advanced materials, one of the key pillars of its future growth.
Eager to sustain its customers’ strong growth, in particular in automotive, 3D-printing, and in consumer goods markets such as sports and electronics, Arkema announces an investment plan of some 300 million euros over five years in the biosourced polyamide 11 chain. This major investment will enable the Group to increase by 50% its polyamide 11 global production capacities. The project falls in line with Arkema’s strategy to speed up its development in advanced materials, one of the key pillars of its future growth, sustained by a unique portfolio of innovations around the main sustainable development trends.
Arkema today announces a project to double its methyl mercaptan production capacity at its Kerteh site in Malaysia to support the strong growth of the animal feed, petrochemical and refining markets in Asia and to strengthen its world leading position in high value added sulfur derivatives.
To support the growth of Sartomer, the world leader in specialty photocure resins, Arkema announces a project to expand by over 30% production capacity at its Nansha facility in China. This new production line will in particular help meet strong customer demand in Asia in the electronics, 3D-printing and inkjet printing cutting-edge markets.
Presenting its long-term growth strategy at its Capital Markets Day on 11 July, Arkema affirms its determination to speed up its development in specialties, which should account for more than 80% of the Group’s sales by 2023. Confident to achieve its 1.3 billion euro EBITDA target in 2017 and in line with its objectives set out for 2020, Arkema announces ambitious financial objectives for 2023 supported by the announcement of several major investment projects in Asia, its innovation drive to address main societal challenges, and its bolt-on acquisition strategy in adhesives.
Arkema files a new complaint with the European Commission against Honeywell for abuse of dominant position with respect to patents covering the use of the refrigerant 1234yf in car air conditioning systems.